Drug absorption from the gastrointestinal (GI) tract is a highly complex process dependent
upon numerous factors including the physicochemical properties of the drug, characteristics …

Obesity has been and continues to be an epidemic in the United States. Obesity has been
addressed in multiple health initiatives, including Healthy People 2010, with no state …

Background: Small intestinal bacterial overgrowth (SIBO) has been proposed to be common
in irritable bowel syndrome (IBS), with altered small-bowel motility as a possible …

Commensal bacteria inhabiting the human intestine (ie, intestinal microflora) participate in
the development and maintenance of gut sensory and motor functions, including the …

The effect of an intestinal microflora consisting of selected microbial species on myoelectric
activity of small intestine was studied using germ-free rat models, with recording before and …

Intestinal failure (IF) is the critical reduction of the gut mass or its function below the minimum
needed to absorb nutrients and fluids required for adequate growth in children. Severe IF …

Background Whether intestinal dysmotility and the use of a proton pump inhibitor (PPI) either
independently or together contributes to small intestinal bacterial overgrowth (SIBO), and/or …

Neurohumoral substances and their receptors play a major part in the complex regulation of
gastrointestinal motility and have therefore been the predominant targets for drug …

Introduction Roux-en-Y gastric bypass (RNYGB) surgery offers an effective and enduring
treatment for morbid obesity. Gastric bypass may alter gastrointestinal (GI) flora possibly …

Background Tracking an ingested magnet by the Magnet Tracking System MTS-1 (Motilis,
Lausanne, Switzerland) is an easy and minimally-invasive method to assess gastrointestinal …